Abstract
Hepatoblastoma is a malignant pediatric liver tumor. The currently used diagnostic serum marker for hepatoblastoma, a-fetoprotein (AFP), is not always reliable in infants with hepatoblastoma, due to the physiologically elevated levels of AFP in this age group. In this report, we show that Delta-like 1 homolog (DLK1), a protein highly expressed during fetal development, but almost completely absent after birth, and an established liver-stem cell marker, is a new candidate serum marker of hepatoblastoma, especially in young infants. Pediatr Blood Cancer 2012;59:743745. (c) 2011 Wiley Periodicals, Inc.
| Original language | English |
|---|---|
| Pages (from-to) | 743-745 |
| Number of pages | 3 |
| Journal | Pediatric Blood & Cancer |
| Volume | 59 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Oct 2012 |
Keywords
- DLK1
- hepatoblastoma
- serum marker
- CHILDHOOD HEPATOBLASTOMA
- LIVER-TUMORS
- PROTEIN DLK
- EXPRESSION
- CHILDREN
Fingerprint
Dive into the research topics of 'DLK1, a serum marker for hepatoblastoma in young infants.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver